PATENT CLAIM ANALYSIS

Application Number: 15885085
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-03
Patent Classification: ["424", "449000"]

Abstract:
Provided is a transdermal formulation including a transdermal absorption enhancer including an aliphatic hydrocarbon derivative and a pyrrolidone derivative; and a benzene diamine derivative for preventing or treating dementia, Alzheimer's disease, and hair loss.

Claim (Index 18):
A method for preventing, treating, or improving dementia, Alzheimer's dementia or hair loss, comprising administrating the transdermal formulation of  claim 1  to a subject in need thereof.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.34483
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15885345', '14004889', '15885483', '13503198', '10900804']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6958520743229504
- 35 USC 102 Novelty (BERT): 0.4985333171610561
- Combined Prediction Score: 0.676120198606761
- Mean Citation Score: 169.79663200000005
- Max Citation Score: 185.90228
- Similarity Product: 112.33913414378642

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test